Medicine and Dentistry
Cystic Fibrosis
100%
Cystic Fibrosis Transmembrane Conductance Regulator
40%
Ivacaftor
38%
Tezacaftor
34%
Patient with Cystic Fibrosis
25%
Health Care
19%
Lumacaftor
18%
Management of Cystic Fibrosis
17%
Secretin
17%
Collecting Duct
15%
COVID-19
14%
Sodium Bicarbonate
14%
Patient-Reported Outcome
14%
Early Intervention
14%
Cohort Analysis
14%
Solid Organ Transplantation
14%
Universal Health Care
14%
Pendrin
13%
Urinary System
12%
Secretion (Process)
11%
Metabolic Alkalosis
10%
Base
9%
Remote Sensing
8%
Consultation
8%
Disorders of Calcium Metabolism
6%
Outpatient
6%
Pharmacology, Toxicology and Pharmaceutical Science
Cystic Fibrosis
71%
Tezacaftor
34%
Ivacaftor
34%
Dicarbonate
28%
Cystic Fibrosis Transmembrane Conductance Regulator
26%
Base
15%
Aciduria
14%
Secretin
12%
Disease
5%
Biological Marker
5%
Nursing and Health Professions
Cystic Fibrosis
28%
Ivacaftor
19%
Tezacaftor
19%
Universal Health Care
14%
Patient-Reported Outcome
14%
Health Care
14%
Remote Sensing
7%
Teleconsultation
7%
Outpatient
5%
